Comparison of the Efficacy and Safety of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Subjects with Moderate-to-severe Rheumatoid Arthritis: Results of a Randomised Double-Blind Study.
RMD OPEN（2024）
关键词
Arthritis, Rheumatoid,Biosimilar Pharmaceuticals,Biological Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要